BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
10.58
+1.54 (17.04%)
Aug 3, 2026, 12:55 PM EDT - Market open
BioAge Labs Market Cap
BioAge Labs has a market cap or net worth of $470.31 million as of August 3, 2026. Its market cap has increased by 218.42% in one year.
Market Cap
470.31M
Enterprise Value
84.14M
1-Year Change
218.42%
Ranking
Category
Stock Price
$10.58
ChartMarket Cap Chart
Since the IPO on September 26, 2024, BioAge Labs's market cap has decreased from $615.01M to $470.31M, a decrease of -23.53%. That is a compound annual growth rate of -13.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 470.31M | -0.85% |
| Dec 31, 2025 | 474.36M | 128.54% |
| Dec 31, 2024 | 207.56M | -66.25% |
| Sep 26, 2024 | 615.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tilray Brands | 615.69M |
| Aquestive Therapeutics | 463.60M |
| Kamada | 418.44M |
| Canopy Growth | 388.19M |
| Evolus | 384.59M |
| Emergent BioSolutions | 372.53M |
| Akebia Therapeutics | 354.10M |
| Organogenesis Holdings | 304.96M |